Between the utility and hazards of phosphorus through the centuries

Ci spiace, ma questo articolo è disponibile soltanto in Inglese Americano. Per ragioni di convenienza del visitatore, il contenuto è mostrato sotto nella lingua alternativa. Puoi cliccare sul link per cambiare la lingua attiva.

Abstract

Phosphorus has been shown to be a predictor of cardiovascular mortality in kidney disease subjects. Phosphorus was discovered in 1669 and was considered a philosopher’s stone, it was used as medicament but there were reported deaths after its  use. High serum levels of phosphorus are associated with increased risk for cardiovascular disease in the general population  in subjects free from chronic kidney disease. Phosphorus can be defined as a useful and hazardous element for public health.

Key words: calcification, phosphorus, pollution, public health, Saint Agustine

 

Introduction

Phosphorus is a recognized physiologically crucial anion involved in more than one million of metabolic steps in humans and animals with a very fascinating history [1] [2]. During the Roman Empire, when the Romans used to collect large quantities of urine for industrial use, to brush teeth, to attend wounds and to whiten woolen togas;  it is now known that phosphorus is an important component of detergents. Suetonious and Dio Cassius reported the method to collect the urine in Pompei: men walking in the streets of Pompei were invited to give the urine and their testicles were sqeezed if they were not able to urinate [1] [2]. This was clearly painful and the men seemed to howl as do barking dogs hence the word “latrina” from “latrato” (barking). The presence of phosphorus in the nature was reported by Saint Agustine, the Christian theologian philosopher who lived from 340 to 430 AD and noted a perpetual light coming from the sepulchers of early Christians. This is now thought to be the result of the production of self-igniting phosphorus-containing gases arising from decaying bodies [3]. In the 14th century, Achid Bechil and later Teophrastus Bombastus von Hohenheim, the Swiss alchemist known as Paracelsus who lived from 1493 to 1541, mentioned that the distillation urine produced unknown substances [1]. But the clear linkage between phosphorus and urine was reported by the merchant and amateur alchemist Henning Brandt who in 1669 distilling 5500 liter of horse urine obtained 120 grams of a white substance that gave off a white light. He was impressed because he thought that the new substance was the philosopher’s stone expected to turn base metals like lead in gold. The substance was named phosphorus from the ancient Greek phos, meaning light, and phorus, meaning bringing. In the following years numerous alchemists and scientists as Ambrose, Goodfrey, Kraft, Kunkel, Hensing, Gahn and Kramer studied this new substance and its properties [1] [2] [3].

Phosphorus as a medicament

In 1675 Johann Lincke, apothecary in Leipzig, was the first to sell phosphorus-containing Kunkel’s pills to cure colic, asthma, fever, tetanus, apoplexy and gout [3]. Evidence of phosphorus content in the brain was described by Thomas Hensing in 1719 who suggested its relation to mental ability, and in 1730 Kramer considered phosphorus an effective remedy for epilepsy and depression [3]. In 1796, Leroy suggested the use phosphorus for the treatment of tubercolosis at a dose of 3-8 mg/day. In 1817 Annibale Omodei (Figure 1) suggested the use of phosphorus for the treatment of fever, epilepsy and paralysis but treated patients died [3]. In 1825 and in 1854 Pietro Moscati and Glover respectively examined various Galenicals used as medicaments and suggested various doses for phosphorus. In addition, Glover (Figure 2) reported a formulation of phosphorus, chloroform and cod liver to treat scrofula and tuberculosis [2]. In 1876 The British Medical Journal reported the use of phosphorus pills in British Pharmacopoeia (Figure 3) and Ashburton Thompson in his “Phosphorus in Medicine” published in 1874 considered the use of phosphorus in veneral diseases, nervous exhaustion, melancholia, softening of the brain, pneumonia, hysteria, apoplectic paralysis, impotence, migraine, epilepsy, cholera, assorted skin diseases, alcoholism, tubercolosis, amaurosis, cataract, glaucoma, tooth ache and neuralgia [3]. In 1930 a paper published in the Journal of the American Association recommended the use of phosphorus to stimulate the formation of new blood cells and to promote growth [1] [2] [3].

In 1935 a paper of Coltart published in Lancet suggested the use of phosphorus as a nerve tonic. Phosphorus was considered also as good agent to stimulate the cognitive activity [3]. [3]

Phosphorus as a hazardous element

The first real evidence of phosphorus as a hazardous element was reported by Orfila in 1817 when he noted that the injection of phosphorus into the jugular vein of a dog caused sudden death [2] [3]. In 1907 in Germany several women died after the ingestion of solution containing hundred match heads used for abortions  [2] [3]. Phosphorus was used in soup, cake, tea, rum to commit. Mary Wilson was a famous poisoner who murdered two husbands using phosphorus in their foods [2] [3].

During the last World War and in contemporary war conflicts phosphorus was used for making burning bombs which have caused millions of victims. Today phosphorus is still used as toothpaste, fertilizer, detergent, and in water purification form perpetual algal bloom detected in 1950s in the lakes of North America. In 1960, the British Dental Journal and British Journal of Industrial Medicinereported cases of phossy jaw disease in workers in military factories using phosphorus to produce bomb [2] [3].

In 1972, the USA and Canada agreed to limit the concentration of phosphorus to 1 mg. per liter in water discharged into the lakes. This was clear knowledge of phosphorus as responsible for water and air pollution. In 1977, the USA Environmental Protection Agency published recommendations for the use of phosphorus to avoid water and air pollution. Nephrologists in 2000s have demonstrated that phosphorus is responsible for high morbidity and mortality due to cardiovascular calcification in persons with Chronic Kidney Disease (CKD), attributing to phosphorus a key role in the calcification process of the arterial smooth muscle cells [4] (full text) [5] [6] [7] [8] (full text) [9] [10] [11] [12] [13] [14] [15].

Zyad reported that phosphate induced vascular calcification is mediated through the activation of mitochondrial reactive oxygen species and p65 nuclear translocation [15]. Phosphate entry into the cells via Pit-1 or possibly other transport mechanisms and stimulates mitochondrial membrane potential and leads to increased production of reactive oxygen species (ROS). Superoxide and ROS activate the nuclear factor kB (NK-kB) pathway with IkBα phosphoyrilation and subsequent proteasome degradation. The activated NF-kB is then translocated into the nucleus, where it binds to specific sequences of DNA and leads to increased expression of osteogenic transcription factors. The activation of membranous ossification programs leads to phenotypic changes in the cell as well as the release of membranes vesicles and apoptotic bodies, both containing hydroxyapatite crystals [15]. High phosphorus serum levels are strongly and independently associated with a more rapid decline of renal function in patients with advanced CKD [14]. Recently it was hypothesized that phosphorus could be involved in carcinogenesis: as a result a fascinating question arises whether dietary Pi intake modify cancer cell survival in animals and humans. In fact phosphorus alters certain serine/threonine kinases (Akt/protein kinase B), that are crucial regulators of cell proliferation, differentiation and metabolism [16]. It has also been reported that phosphorus is responsible for a chronic low grade of inflammation [15] [16] that could be related with telomere dysfunction via increasing ROS-mediated DNA damage and thus accelerate the accumulation of senescent cells, initiating a circulus vitiosus in which cell senescence aggravated by chronic inflammation, limits tissue regeneration and accelerates ageing [16].

Conclusion

On the basis of the previous considerations the daily intake of phosphorus exceeding 800 mg needed for the metabolic activity in humans is potentially dangerous. Many authors have suggested to reduce the daily quantity of protein originating phosphate but this can predispose to malnutrition especially in CKD patients trated conservatively or chronic haemodialysis [8] (full text) [11].  It is mandatory to avoid foods containing polyphosphates [11] [12] [13] [14]  and beverages containing ortophosphoric acid [11] and drugs containing phosphorus [17]. Now is time to appeal to governments for interventions to abolish or limit and reconsider the use of phosphorus in dietary products. We must encourage CKD patients to adhere to phosphate binder therapy and to personalize their better hypophosphoremic therapy. Phosphorus is a useful element for the metabolic activity in humans and animals but it can become hazardous when it exceeds the serum normal range. We are convinced that it is necessary to redefine the normal range of serum phosphorus level considering the reported increased mortality risk due to cardiovascular calcifications in patients with phosphorus serum levels more than 3,5 mg/dl [18] (full text). Phosphorus has been shown to be a predictor of cardiovascular death in kidney disease subjects and in general community [19].

References

[1] Bombastus von Honhenheim T (Paracelsus): De Secretis natura misteriis libri decem.1582,Basil, Petrum Perna Editor

[2] Emsley J: The 13th element:the sordid tale of murder,fire and phhosphorus.2000 New York,Wiley Editor

[3] Savica V, Santoro D, Mallamace A et al. Phosphorus: the philosopher’s stone discovered in 1669. Journal of nephrology 2009 Nov-Dec;22 Suppl 14:60-3

[4] Giachelli CM Vascular calcification: in vitro evidence for the role of inorganic phosphate. Journal of the American Society of Nephrology : JASN 2003 Sep;14(9 Suppl 4):S300-4 (full text)

[5] Finn WF Phosphorus management in end-stage renal disease. Seminars in dialysis 2005 Jan-Feb;18(1):8-12

[6] Savica V, Calò LA, Caldarera R et al. Phosphate salivary secretion in hemodialysis patients: implications for the treatment of hyperphosphatemia. Nephron. Physiology 2007;105(3):p52-5

[7] Savica V, Calò LA, Granata A et al. A new approach to the evaluation of hyperphosphatemia in chronic kidney disease. Clinical nephrology 2007 Oct;68(4):216-21

[8] Savica V, Calò LA, Monardo P et al. Phosphate binders and management of hyperphosphataemia in end-stage renal disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association – European Renal Association 2006 Aug;21(8):2065-8 (full text)

[9] Savica V, Bellinghieri G, Santoro D et al. Phosphorus-related mechanisms of vascular calcification. Archives of internal medicine 2007 Nov 26;167(21):2368

[10] Bellinghieri G, Santoro D, Savica V et al. Emerging drugs for hyperphosphatemia. Expert opinion on emerging drugs 2007 Sep;12(3):355-65

[11] Savica V, Calò LA, Monardo P et al. High phosphate content beverages in dialysis patients: relevance for hyperphosphatemia and cardiovascular risk. Nutrition, metabolism, and cardiovascular diseases : NMCD 2008 Oct;18(8):e39-40

[12] Savica V, Calo’ LA, Santoro D, et al: Salivary phosphate secretion in chronic kidney disease.2008,J Ren Nutr,;18:158-164

[13] Dhingra R, Sullivan LM, Fox CS et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Archives of internal medicine 2007 May 14;167(9):879-85

[14] Caravaca F, Villa J, García de Vinuesa E et al. Relationship between serum phosphorus and the progression of advanced chronic kidney disease. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 2011;31(6):707-15

[15] Zyad Al Ali: Phosphate,oxidative stress, and nuclear factor kB activation in vascular calcification.2011.Kidney Intern; 79 (10):1044-7

[16] Jurk D, Wilson C, Passos JF et al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nature communications 2014 Jun 24;2:4172

[17] Sultana J, Musazzi UM, Ingrasciotta Y et al. Medication is an additional source of phosphate intake in chronic kidney disease patients. Nutrition, metabolism, and cardiovascular diseases : NMCD 2015 Oct;25(10):959-67

[18] Kestenbaum B, Sampson JN, Rudser KD et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. Journal of the American Society of Nephrology : JASN 2005 Feb;16(2):520-8 (full text)

[19] Savica V: Phosphorus: A useful and dangerous element for the general community. pp 99-106 In: De Santo NG et Al: Survival is not enough; for Wordld Kidney Day, 2014, Italian Institute for Philosophical Studies Editor